
Keywords: نورورتین; Parkinson's disease; Neurotrophic therapy; Clinical trials; Systematic review/meta-analysis; Neurotrophic factors; CI; confidence interval; DA; dopaminergic/dopamine; GDNF; glial cell line-derived neurotrophic factor; NTF; neurotrophic factor; NTN; neurtu